DIOSMIN MARKET REPORT OVERVIEW
The Diosmin Market was valued at USD 673.6 million in 2024 and is projected to reach USD 725.5 Million in 2025, growing to USD 1313.3 Million by 2033, with exhibiting CAGR of 7.7% during the forecast period.
The global Diosmin Market has experienced tremendous growth in recent years, fueled by technological innovation and growing demand from different industries. The market has grown consistently over the historical period 2020-2023, with high investments driving innovation. In the future, the forecasted period of 2025-2033 is anticipated to experience rapid growth, fueled by growing adoption and new market trends. The industry is led by the top three major players - Suan Farma, Bannerbio, Interquim, who are still leading through strategic growth and product development. Top Growing Region Europe is expected to grow at the fastest rate, driven by rising industrialization, digitalization, and supportive government policies.
The diosmin marketplace revolves round a flavonoid compound mainly extracted from citrus fruits, broadly used for its therapeutic attributes. Diosmin is utilized in prescribed drugs, particularly for treating venous disorders like continual venous insufficiency, hemorrhoids, and varicose veins because of its vasoprotective and anti-inflammatory effects. The marketplace is pushed via growing attention of natural health products, growing incidences of venous illnesses, and a shift toward plant-primarily based medicinal drugs. Europe and North America are key regions, with growing call for also located in rising markets. The enterprise consists of each artificial and herbal diosmin, with ongoing studies into its broader medicinal programs.
COVID-19 Impact
The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.
The COVID-19 pandemic negatively impacted the diosmin market growth via disrupted deliver chains, decreased production capacities, and shifting healthcare priorities. With global lockdowns and journey regulations, the delivery of raw materials for diosmin manufacturing, particularly from citrus sources, was restrained, main to delays and shortages. Additionally, healthcare structures global prioritized COVID-19 treatment, reducing focus on non-essential or optionally available remedies, which includes those for venous disorders in which diosmin is commonly used. This shift in attention led to a decline in call for diosmin-based merchandise throughout the pandemic. Furthermore, financial uncertainty and reduced patron spending on healthcare products also contributed to a temporary slowdown in marketplace boom.
LATEST TRENDS
Increasing Integration of IoT and Smart Technologies Helps Market to Grow
A key fashion driving the increase of the diosmin marketplace is the increasing call for for natural and plant-based totally prescribed drugs. Consumers are moving toward bioflavonoids like diosmin due to their herbal origin and minimum aspect effects. Additionally, there may be a developing attention on studies and development to extend diosmin's healing packages past venous issues, exploring its capacity in treating different situations like lymphedema and diabetic retinopathy. The rising recognition of nutraceuticals and nutritional supplements incorporating diosmin for vascular health also supports marketplace growth, especially in areas with growing old populations and heightened health cognizance.
DIOSMIN MARKET SEGMENTATION
By Type
Based on type the global market can be categorized into powder, grannular.
- Powder: Diosmin in powder form is extensively utilized in pharmaceutical formulations, such as drugs and pills. It allows for clean blending with other components and specific dosing, making it ideal for generating numerous dosage forms.
- Granular: Granular diosmin is typically used in applications where a managed release is needed, or in formulations requiring a selected particle length. It is preferred for some styles of dietary supplements and specialized pharmaceutical applications.
By Application
Based on application the global market can be categorized into prescription medicine, natural supplements.
- Prescription Medicine: Diosmin is generally utilized in prescription medicines to treat venous disorders which include persistent venous insufficiency, varicose veins, and hemorrhoids. These pharmaceutical formulations are commonly regulated and prescribed by using healthcare professionals.
- Natural Supplements: Diosmin is likewise to be had with-in the form of herbal supplements, regularly combined with different bioflavonoids, aimed toward improving vascular fitness, decreasing inflammation, and assisting usual circulatory characteristics. These dietary supplements are typically to be had over the counter and cater to the developing call for plant-based totally and natural fitness merchandise.
DRIVING FACTORS
Rising Prevalence of Venuous Disorders Drives the Market
The growing prevalence of venous issues, such as chronic venous insufficiency, varicose veins, and hemorrhoids, is a full-size growth factor for the diosmin market. As existence turn out to be more sedentary, especially in evolved nations, those situations are getting more commonplace. Diosmin's established efficacy in improving venous tone, lowering inflammation, and enhancing microcirculation makes it a favored preference in treating these situations. As consciousness grows amongst healthcare vendors and patients, the call for diosmin-primarily based prescription medicinal drugs is anticipated to upward thrust, driving market growth.
Shift Towards Natural and Plant-Based Products Drives the Market
There is a developing client desire for herbal and plant-primarily based merchandise, driven by accelerated health focus and worries about synthetic chemicals' aspect results. Diosmin, being a bioflavonoid derived from citrus culmination, aligns with this trend. This shift is specifically obtrusive within the nutraceutical and nutritional supplement markets, where customers are looking for herbal answers for vascular health and well-known wellness. The expanding marketplace for natural dietary supplements that comprise diosmin is contributing to the general growth, as more human beings look for herbal approaches to manage and save you venous issues and other related fitness issues.
RESTRAINING FACTORS
Limited Awareness and Availability in Emerging Markets Restrains the Market Growth
One restraining aspect within the growth of the diosmin market is the restricted consciousness and availability in rising markets. While diosmin is well-established in Europe and North America, its presence in developing regions is less prominent because of decrease awareness among healthcare specialists and clients. Additionally, the provision of diosmin-primarily based merchandise is regularly restricted in those markets, in addition hindering boom. High expenses associated with manufacturing and importation, coupled with constrained local manufacturing abilities, additionally make contribution to its constrained accessibility. Overcoming those barriers calls for focused education, advertising efforts, and funding in local production to make bigger diosmin's international attainment.
OPPORTUNITY
Expanding Medical Applications
Diosmin has demonstrated efficacy in improving symptoms of chronic venous disease (CVD), including reducing leg swelling and enhancing the quality of life. A clinical study found that patients treated with diosmin showed a statistically significant reduction in mid-calf circumference and Venous Clinical Severity Scores within 4 to 8 weeks, highlighting its potential for broader medical use.
Advancements in Bioavailabilit
Diosmin has low water solubility, which traditionally limited its clinical application. However, recent advancements in formulations, such as micronized purified flavonoid fractions (MPFF), have improved its pharmacokinetics, making it more effective for treating conditions like venous insufficiency and varicose veins.
CHALLENGES
Limited Market Penetration in the U.S.
Despite its proven benefits, diosmin-based pharmacological treatments are not widely used in the U.S. healthcare market. There remains skepticism regarding its routine use due to the lack of widespread clinical adoption compared to European markets
Regulatory and Research Gaps
While diosmin exhibits multiple pharmacological properties, including anti-inflammatory and antioxidant effects, there are no officially recognized drug targets. More research is required to fully understand its mechanisms, delaying its approval for broader therapeutic applications
DIOSMIN MARKET REGIONAL INSIGHTS
The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.
Request a Free sample to learn more about this report.
Europe as the Pivotal Driver in the Market due to Widespread Use of Diosmin Based Products
Europe is the main region inside the worldwide diosmin market share, driven through high consciousness and widespread use of diosmin-based totally merchandise for treating venous problems. Countries like France, Spain, and Italy have properly-established markets for diosmin, both in prescription medicines and natural supplements. The area's strong healthcare infrastructure, coupled with a substantial getting old populace prone to venous conditions, fuels demand. Additionally, Europe is a key hub for the research and development of flavonoids, including diosmin, in addition solidifying its leadership. Regulatory aid for natural and plant-primarily based treatments also contributes to Europe's dominant position in the international diosmin market.
KEY INDUSTRY PLAYERS
Key Industry Players Shaping the Market Through Innovation and Market Expansion
Key enterprise players are shaping the diosmin marketplace through innovation and marketplace expansion by means of specializing in several strategic procedures. These include making an investment in superior manufacturing technologies to decorate the purity and performance of diosmin production. Companies also are increasing their product portfolios to include various formulations, consisting of novel transport structures and combos with different bioflavonoids. Additionally, they may be penetrating emerging markets through growing consciousness and accessibility thru strategic partnerships and localized production. These efforts now not most effective force market increase however also cater to evolving purchaser choices for herbal and powerful health solutions.
TOP INDUSTRY PLAYERS
- Shanghai Freemen (China)
- Interquim (Spain)
- Bannerbio (China)
- Suan Farma (India)
- Penam Laboratories (India)
INDUSTRIAL DEVELOPMENT
October 2024: The Diosmin market is encountering development because of rising familiarity with vascular wellbeing. Numerous drug and nutraceutical organizations are zeroing in on extending their product offerings to incorporate Diosmin-based supplements for treating venous deficiency and related messes
September, 2023: An industrial development within the diosmin marketplace was delivered via EirGenix, Inc., a Taiwan-based biopharmaceutical enterprise. EirGenix accelerated its production skills via investing in superior manufacturing centers for excessive-purity diosmin. This improvement enabled the enterprise to provide diosmin at a bigger scale with improved consistency and quality, meeting the increasing international call for each pharmaceutical and nutraceutical programs.
REPORT COVERAGE
The diosmin market is poised for boom driven via the growing incidence of venous disorders and increasing customer preference for natural dietary supplements. Europe remains the main place, with superior production and high marketplace penetration. Key industry players are advancing the marketplace through technological improvements and expansion into rising areas. However, demanding situations along with restricted cognizance in sure markets and manufacturing prices want to be addressed. Overall, the market is about to amplify as demand for effective, herbal fitness solutions continues to rise, supported via ongoing research and strategic marketplace tendencies.
- 26635692
- Europe
- 87
Clients
Top Trending
Contact Information
Frequently Asked Questions
-
What value is the Diosmin market expected to touch by 2033?
The Diosmin market is expected to reach USD 1313.3 million by 2033.
-
What CAGR is the Diosmin market expected to exhibit by 2033?
The Diosmin market is expected to exhibit a CAGR of 7.7 % by 2033.
-
What are the driving factors of the Diosmin market?
Rising prevalence of venous disorders and shift towards natural and plant-based products are some of the driving factors of the market.
-
What is the key Diosmin market segments?
The key market segmentation that you should be aware of, which includes, based on types Diosmin market is classified into powder, granular. Based on the application of the Diosmin market into prescription medicine, natural supplement.